source
- Oura to acquire AI virtual primary care partner Counsel Health for $625MThe companies have worked together since June, and more recently had shared plans to partner on CMS' 10-year ACCESS Model.Fierce Biotech · 7h ago↗ source
- STAT+: GLP-1s are given an FDA warning for rare eye condition riskThe FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”STAT · 8h ago↗ source
- Recon: Bayer wins FDA approval for stroke prevention drug; Third Rock enters $2B partnership with AI-focused Chinese biotechWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 23h ago↗ source